Vietnam lifts substandard imported drugs from market

The Drug Administration of Vietnam on September 12 called for inspection of all consignments of imported medicines, after drug quality control agencies discovered that many foreign drugs had failed to meet national standards.

For instance, Clavophynamox 1000, Nalidixic acid tablets BP 500mg and Piroxicam imported by Pharmaceutical Company No.1 and manufactured by Flamingo Pharmaceutical Pvt. Ltd Company in India, could not meet quality standards. Umedica Laboratories Pvt. Ltd Company from India is said to have exported substandard drugs into Vietnam three times.

In addition, several international pharmaceutical companies have also sold substandard medicines in Vietnam, including Apotex Inc from Canada; Pfizer PGM from France; Denk Pharma GmbH & Co. KG from Germany; Deawoo, Daehwa Pharm and Dae Han New Pharm Company from South Korea.

Nguyen Viet Hung, Deputy Head of Drug Administration of Vietnam, said from January 1, 2011 to August 23, 2013, the administration has detected 37 pharmaceutical companies from ten nations that sold low quality drugs to Vietnam, of which 25 are Indian companies.

Consequently, the administration has asked importers to check the quality of medicines before launching in the market.

After clearance they must be stored in warehouses where drug quality control agencies in districts or provinces will take samples for testing.

Later, the National Institute of Drug Quality Control will conduct further checks.

By Tuong Lam - Translated by Uyen Phuong

Other news